UNSPSC 51262409: Amosulalol monohydrochloride

This classification denotes an adrenergic antagonist with the molecular formula C18H24N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O4S698PEE, chemically known as benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, hydrochloride (1:1), but more generally known as amosulalol monohydrochloride, which bears US NIH Compound Identifier 123707.

European Medicines Agency schedules amosulalol monohydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05478MIG. Most nations, for tariff purposes, schedule amosulalol monohydrochloride under HS 29350090. SMILES: CC1CCC(CC1S(=O)(=O)N)C(CNCCOC2CCCCC2OC)O.CL.

UNSPSC 51262409 Amosulalol monohydrochloride is a Commodity code that nominally describes a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code does not align with that narrow scope. The one recent opportunity tagged to this code — Seminole County, Florida's IFB for naloxone and drug deactivation systems — represents emergency response and public health supplies rather than the pharmaceutical compound the code name implies. State and local governments appear to be using this code inconsistently or as a catch-all for pharmaceutical and medical-supply acquisitions outside traditional pharmaceutical distribution channels. The work involves procurement of finished naloxone kits and related drug management systems for public health and emergency preparedness, not manufacture or distribution of raw pharmaceutical intermediates.

Seminole County, a Florida county government, issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing, and standard compliance requirements including E-Verify, drug-free workplace certification, and worker's compensation insurance. The bid deadline was July 26, 2023, and the procurement appears potentially funded through FEMA with associated federal environmental compliance obligations. The code shows minimal recent activity; this single opportunity provides insufficient evidence of sustained or widespread state and local solicitation under this category, suggesting either narrow utilization of the code or a data-classification anomaly.